Brief: Anixa Biosciences Announces World Health Organization (Who) Approval Of International Non-Proprietary Name For Its Car-T Therapy, Marking A Key Milestone Toward Global Recognition And Future Commercialization
17/11/2025 13:18
Anixa Biosciences Inc ANIX.O: ANIXA BIOSCIENCES ANNOUNCES WORLD HEALTH ORGANIZATION (WHO) APPROVAL OF INTERNATIONAL NON-PROPRIETARY NAME FOR ITS CAR-T THERAPY, MARKING A KEY MILESTONE TOWARD GLOBAL RECOGNITION AND FUTURE COMMERCIALIZATION Source text: ID:nPn5RtVtfa Further company coverage: ANIX.O
Recent news on Anixa Biosciences
See all newsBrief: Anixa Biosciences Announces First Case Of Stable Disease For Three Months In Ovarian Cancer Car-T Clinical Trial
US RESEARCH ROUNDUP- Allstate, Autozone, Vertex Pharmaceuticals
Anixa Biosciences Inc reports results for the quarter ended July 31 - Earnings Summary
Anixa Biosciences Inc expected to post a loss of 9 cents a share - Earnings Preview
Factbox: Moderna-Merck melanoma vaccine leads race for first therapeutic cancer vaccine